Document Type

Article

Loading...

Media is loading
 

Publication Date

8-3-2022

Abstract

Racial disparities have occurred in COVID-19’s health effects and fatalities. They have persisted through the rollout of COVID-19 vaccines too, which saw a greater uptake in socioeconomically privileged segments of the population. These outcomes did not have to occur. Olatunde Johnson of Columbia Law School discusses how regulators could have made different policy design choices to promote greater equity in the vaccine rollout—and she draws key lessons not only for the next public health emergency but also for improving racial equity more generally.

Comments

Hosted by Cary Coglianese, Director of the Penn Program on Regulation.

Produced by Patty McMahon

Music by Joy Ike

Share

COinS